1. Home
  2. CODX vs DSS Comparison

CODX vs DSS Comparison

Compare CODX & DSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CODX
  • DSS
  • Stock Information
  • Founded
  • CODX 2013
  • DSS 1984
  • Country
  • CODX United States
  • DSS United States
  • Employees
  • CODX N/A
  • DSS N/A
  • Industry
  • CODX Medical/Dental Instruments
  • DSS Containers/Packaging
  • Sector
  • CODX Health Care
  • DSS Consumer Discretionary
  • Exchange
  • CODX Nasdaq
  • DSS Nasdaq
  • Market Cap
  • CODX 9.8M
  • DSS 8.9M
  • IPO Year
  • CODX 2017
  • DSS N/A
  • Fundamental
  • Price
  • CODX $0.28
  • DSS $0.89
  • Analyst Decision
  • CODX Buy
  • DSS
  • Analyst Count
  • CODX 2
  • DSS 0
  • Target Price
  • CODX $5.50
  • DSS N/A
  • AVG Volume (30 Days)
  • CODX 399.9K
  • DSS 187.4K
  • Earning Date
  • CODX 08-07-2025
  • DSS 08-12-2025
  • Dividend Yield
  • CODX N/A
  • DSS N/A
  • EPS Growth
  • CODX N/A
  • DSS N/A
  • EPS
  • CODX N/A
  • DSS N/A
  • Revenue
  • CODX $3,497,583.00
  • DSS $20,180,000.00
  • Revenue This Year
  • CODX N/A
  • DSS N/A
  • Revenue Next Year
  • CODX $42.11
  • DSS N/A
  • P/E Ratio
  • CODX N/A
  • DSS N/A
  • Revenue Growth
  • CODX N/A
  • DSS 12.88
  • 52 Week Low
  • CODX $0.23
  • DSS $0.72
  • 52 Week High
  • CODX $2.23
  • DSS $1.67
  • Technical
  • Relative Strength Index (RSI)
  • CODX 47.58
  • DSS 46.74
  • Support Level
  • CODX $0.27
  • DSS $0.88
  • Resistance Level
  • CODX $0.30
  • DSS $0.96
  • Average True Range (ATR)
  • CODX 0.03
  • DSS 0.07
  • MACD
  • CODX 0.00
  • DSS -0.00
  • Stochastic Oscillator
  • CODX 54.00
  • DSS 41.67

About CODX Co-Diagnostics Inc.

Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.

About DSS DSS Inc.

DSS Inc is operating a business focused on Five operating segments Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. Currently operates five distinct business lines operate around the globe with primary operations in North America and Asia. Product packaging manufactures, and sells sophisticated custom folding cartons, mailers, photo sleeves and complex three-dimensional direct mail solutions. Biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending through represents its banking and financing business line. Alternative Trading develops and/or acquires assets and investments in the securities trading and/or fund management arena.

Share on Social Networks: